New updates have been reported about Hyro.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hyro has released its 2026 Healthcare AI Agent Benchmark Report, positioning the company at the center of the debate over how health systems can extract financial value from agentic AI in call centers. Based on a survey of 387 director-level and above healthcare leaders across the United States, the report quantifies how integration depth with electronic health records drives return on investment and operational outcomes for Hyro’s target customers.
The data show that 82% of health systems using advanced, configurable EHR integrations with AI agents report annual ROI above $500,000, versus only 18% among organizations relying on standard FHIR-based connections, with 15% of deeply integrated deployments surpassing $1 million in annual ROI compared with 1% for standard setups. Across all respondents, average annual ROI from call center AI agents is $586,000, underscoring the economic case for the type of deep interoperability Hyro has built its platform around.
Beyond ROI, the report highlights that 94% of health systems with deployed AI agents now consider agentic AI critical to patient-facing operations, yet only 59% have standardized performance measurement processes, leaving a sizable gap Hyro can target with analytics and governance capabilities. Staffing shortages were cited by 41% of respondents as the primary driver for AI investment, and on average, AI agents offload 264 administrative hours per month, reinforcing Hyro’s value proposition around workforce relief and capacity creation.
The findings further indicate that most health systems use AI for basic workflows such as rescheduling, cancellations, and appointment verification, which are now considered baseline functionality, while adoption drops sharply for more complex tasks like waitlist and referral management, new patient registration, and new patient scheduling. This supports Hyro’s strategic emphasis on advanced workflows and domain-specific expertise, as the report concludes that real operational differentiation and financial upside reside in these higher-value use cases.
Crucially, 93% of health systems with deep, configurable EHR integrations reach the highest automation benchmarks, compared with 57% to 79% for those with standard connections, reinforcing Hyro’s message that integration quality, rather than the mere presence of an AI agent, determines impact. CEO and Co-Founder Israel Krush notes that the top-performing organizations in the survey mirror Hyro’s own customer base, which prioritizes healthcare-specific AI agents with strong interoperability and both inbound and outbound capabilities, suggesting ongoing demand for Hyro’s platform as systems push to prove ROI on AI investments.
The report, conducted by independent research firm Global Surveyz, provides Hyro with third-party validation that its focus on responsible, deeply integrated AI agents is aligned with where financial and operational gains are greatest in the market. With customers including major health systems and a platform designed to be HIPAA-compliant, scalable, and interoperable with existing workflows, Hyro is positioned to benefit as health systems move beyond pilot projects to standardized measurement, advanced use cases, and higher levels of automation in patient access and call center operations.